You can find the annual or quarterly income statement of Pyxis Oncology Inc here for insights into the performance and operational efficiency of Pyxis Oncology Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Total revenue

--11.04M

----

--2.82M

-100.00%0.00

--0.00

--16.15M

----

Cost of revenue

--2.39M

----

--0.00

--475.00K

----

Operating expenses

53.54%29.33M

-1.23%23.46M

12.67%22.57M

5.35%22.91M

7.53%19.11M

-6.31%23.75M

10.55%20.03M

3.80%21.75M

-53.21%17.77M

-10.70%25.35M

-29.56%18.12M

-33.24%20.95M

131.18%37.97M

144.32%28.39M

333.02%25.73M

-12.15%31.39M

258.72%16.43M

264.07%11.62M

--5.94M

--35.73M

--4.58M

--3.19M

R&D expenses

54.81%21.71M

0.38%17.81M

22.79%17.13M

30.82%17.04M

20.82%14.02M

20.79%17.74M

22.49%13.95M

9.48%13.03M

-61.12%11.61M

-22.84%14.69M

-33.66%11.39M

-40.71%11.90M

313.15%29.85M

142.50%19.03M

435.73%17.17M

-38.76%20.07M

130.20%7.23M

223.67%7.85M

--3.21M

--32.77M

--3.14M

--2.42M

Depreciation, depletion, and amortization

426.73%2.90M

-27.91%527.00K

-8.55%535.00K

-50.54%552.00K

-20.29%550.00K

39.77%731.00K

11.64%585.00K

487.37%1.12M

259.38%690.00K

161.50%523.00K

229.56%524.00K

20.25%190.00K

21.52%192.00K

25.79%200.00K

-26.73%159.00K

39.82%158.00K

-21.39%158.00K

-40.89%159.00K

--217.00K

--113.00K

--201.00K

--269.00K

Operating profit

4.24%-18.30M

1.23%-23.46M

1.41%-19.75M

-308.81%-22.91M

-7.53%-19.11M

6.31%-23.75M

-10.55%-20.03M

73.25%-5.61M

53.21%-17.77M

10.70%-25.35M

29.56%-18.12M

33.24%-20.95M

-131.18%-37.97M

-144.32%-28.39M

-333.02%-25.73M

12.15%-31.39M

-258.72%-16.43M

-264.07%-11.62M

---5.94M

---35.73M

---4.58M

---3.19M

Net non-operating interest income (expenses)

Non-operating interest income

158.62%225.00K

24.74%242.00K

-74.42%99.00K

-67.94%84.00K

-43.14%87.00K

-14.54%194.00K

-2.27%387.00K

-75.42%262.00K

-91.83%153.00K

-68.43%227.00K

141.46%396.00K

11744.44%1.07M

26642.86%1.87M

11883.33%719.00K

2633.33%164.00K

125.00%9.00K

--7.00K

500.00%6.00K

--6.00K

--4.00K

--0.00

--1.00K

Gains from sale of securities

-75.54%375.00K

-67.80%532.00K

-45.23%896.00K

-10.17%1.16M

6.38%1.53M

11.62%1.65M

29.84%1.64M

112.19%1.29M

--1.44M

--1.48M

--1.26M

--607.00K

----

Return on equity

----

--0.00

100.00%0.00

----

--0.00

----

---231.00K

----

--0.00

Special income (expenses)

100.00%0.00

--74.00K

----

---20.96M

----

100.00%0.00

---410.00K

---2.56M

---2.16M

---1.10M

--0.00

Other non-operating income (expenses)

-3.08%692.00K

-2.98%684.00K

-3.39%684.00K

-35.54%515.00K

23.96%714.00K

17.89%705.00K

25.53%708.00K

2002.63%799.00K

--576.00K

--598.00K

--564.00K

--38.00K

--0.00

-100.00%0.00

----

--0.00

--181.00K

----

--0.00

Income before tax

54.94%-17.00M

-3.77%-22.00M

-4.45%-18.07M

-549.82%-21.16M

-141.94%-37.73M

8.01%-21.20M

-8.80%-17.30M

83.08%-3.26M

56.80%-15.60M

16.71%-23.05M

37.79%-15.90M

38.68%-19.24M

-114.52%-36.10M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

-267.53%-16.83M

-344.22%-14.18M

---8.15M

---36.83M

---4.58M

---3.19M

Income tax

150.97%1.10M

--0.00

--283.00K

----

---2.16M

----

Income after tax

49.10%-18.11M

-3.77%-22.00M

-6.09%-18.35M

-549.82%-21.16M

-128.06%-35.57M

8.01%-21.20M

-8.80%-17.30M

83.08%-3.26M

56.80%-15.60M

16.71%-23.05M

37.79%-15.90M

38.68%-19.24M

-114.52%-36.10M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

-267.53%-16.83M

-344.22%-14.18M

---8.15M

---36.83M

---4.58M

---3.19M

Net income from continuous operations

49.10%-18.11M

-3.77%-22.00M

-6.09%-18.35M

-549.82%-21.16M

-128.06%-35.57M

8.01%-21.20M

-8.80%-17.30M

83.08%-3.26M

56.80%-15.60M

16.71%-23.05M

37.79%-15.90M

38.68%-19.24M

-114.52%-36.10M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

-267.53%-16.83M

-344.22%-14.18M

---8.15M

---36.83M

---4.58M

---3.19M

Other net gains and losses

--53.00K

----

Net income attributable to controlling interests

49.10%-18.11M

-3.77%-22.00M

-6.09%-18.35M

-549.82%-21.16M

-128.06%-35.57M

8.01%-21.20M

-8.80%-17.30M

83.08%-3.26M

56.80%-15.60M

16.71%-23.05M

37.79%-15.90M

38.68%-19.24M

-114.52%-36.10M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

-267.53%-16.83M

-344.22%-14.18M

---8.15M

---36.83M

---4.58M

---3.19M

Net income attributable to common shareholders

49.10%-18.11M

-3.77%-22.00M

-6.09%-18.35M

-549.82%-21.16M

-128.06%-35.57M

8.01%-21.20M

-8.80%-17.30M

83.08%-3.26M

56.80%-15.60M

16.71%-23.05M

37.79%-15.90M

38.68%-19.24M

-114.52%-36.10M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

-267.53%-16.83M

-344.22%-14.18M

---8.15M

---36.83M

---4.58M

---3.19M

Basic earnings per share

50.54%-0.29

-0.72%-0.35

-3.65%-0.30

-445.95%-0.35

-65.63%-0.58

37.38%-0.35

30.96%-0.29

88.34%-0.06

66.20%-0.35

34.39%-0.56

47.42%-0.41

43.94%-0.54

-89.18%-1.04

-96.27%-0.85

-216.54%-0.79

13.68%-0.97

-292.03%-0.55

-344.22%-0.43

---0.25

---1.12

---0.14

---0.10

Diluted earnings per share

50.54%-0.29

-0.72%-0.35

-3.65%-0.30

-445.95%-0.35

-65.63%-0.58

37.38%-0.35

30.96%-0.29

88.34%-0.06

66.20%-0.35

34.39%-0.56

47.42%-0.41

43.94%-0.54

-89.18%-1.04

-96.27%-0.85

-216.54%-0.79

13.68%-0.97

-292.03%-0.55

-344.22%-0.43

---0.25

---1.12

---0.14

---0.10

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

